These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16734081)

  • 1. Pharmacokinetic and pharmacodynamic parameters of ramipril and ramiprilat in healthy dogs and dogs with reduced glomerular filtration rate.
    Lefebvre HP; Jeunesse E; Laroute V; Toutain PL
    J Vet Intern Med; 2006; 20(3):499-507. PubMed ID: 16734081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of ramipril and ramiprilat after intravenous and oral doses of ramipril in healthy horses.
    Serrano-Rodríguez JM; Gómez-Díez M; Esgueva M; Castejón-Riber C; Mena-Bravo A; Priego-Capote F; Serrano Caballero JM; Muñoz A
    Vet J; 2016 Feb; 208():38-43. PubMed ID: 26639833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat.
    Levitt DG; Schoemaker RC
    BMC Clin Pharmacol; 2006 Jan; 6():1. PubMed ID: 16398929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nervous and systemic kinetics of ramipril and ramiprilat in the conscious dog.
    Nordström M; Abrahamsson T; Ervik M; Forshult E; Regårdh CG
    J Pharmacol Exp Ther; 1993 Jul; 266(1):147-52. PubMed ID: 8331554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of ramipril and ramiprilat in healthy cats.
    Desmoulins PO; Burgaud S; Horspool LJ
    J Vet Pharmacol Ther; 2008 Aug; 31(4):349-58. PubMed ID: 18638296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics, safety, and efficacy of ramipril after long-term administration in hemodialyzed patients.
    Fillastre JP; Baguet JC; Dubois D; Vauquier J; Godin M; Legallicier B; Luus HG; de la Rey N; Carcone N; Genthon R
    J Cardiovasc Pharmacol; 1996 Feb; 27(2):269-74. PubMed ID: 8720427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple-dose pharmacokinetics of ramipril in patients with chronic congestive heart failure.
    Heintz B; Verho M; Brockmeier D; Lückel G; Maigatter S; Sieberth HG; Rangoonwala B; Bender N
    J Cardiovasc Pharmacol; 1993; 22 Suppl 9():S36-42. PubMed ID: 7514239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid chromatography-mass spectrometric analysis of ramipril and its active metabolite ramiprilat in human serum: application to a pharmacokinetic study in the Chinese volunteers.
    Lu XY; Shen-Tu JZ; Liu J
    J Pharm Biomed Anal; 2006 Feb; 40(2):478-83. PubMed ID: 16181761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of interaction between ramipril and simvastatin.
    Meyer BH; Scholtz HE; Müller FO; Luus HG; de la Rey N; Seibert-Grafe M; Eckert HG; Metzger H
    Eur J Clin Pharmacol; 1994; 47(4):373-5. PubMed ID: 7875191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibition in cirrhotic patients--pharmacokinetics of ramipril.
    Pidlich J; Cichini GM; Reinisch W; Peck-Radosavljevic M; Renner F
    Acta Med Austriaca; 1997; 24(1):15-8. PubMed ID: 9150805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, metabolism and biliary and urinary excretion of oral ramipril in man.
    Verho M; Luck C; Stelter WJ; Rangoonwala B; Bender N
    Curr Med Res Opin; 1995; 13(5):264-73. PubMed ID: 7555035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute haemodynamic effects and pharmacokinetics of ramipril in patients with heart failure. A placebo controlled three-dose study.
    Beermann B; Nyquist O; Höglund C; Jacobsson KA; Näslund U; Jensen-Urstad M
    Eur J Clin Pharmacol; 1993; 45(3):241-6. PubMed ID: 8276048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, pharmacodynamics and bioavailability of the ACE inhibitor ramipril.
    van Griensven JM; Schoemaker RC; Cohen AF; Luus HG; Seibert-Grafe M; Röthig HJ
    Eur J Clin Pharmacol; 1995; 47(6):513-8. PubMed ID: 7768254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of male-female differences in disposition and esterase hydrolysis of ramipril to ramiprilat in healthy volunteers after a single oral dose.
    Vree TB; Dammers E; Ulc I; Horkovics-Kovats S; Ryska M; Merkx ; Ijsbrand
    ScientificWorldJournal; 2003 Dec; 3():1332-43. PubMed ID: 14755115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioequivalence study of two tablet formulations of ramipril in healthy volunteers.
    Allegrini A; Nuzzo L; Zucchelli M; Tavella-Scaringi A; Bucci M; Pavone D; Toniato E; Mezzetti A; Martinotti S; Bonani S
    Arzneimittelforschung; 2009; 59(8):392-6. PubMed ID: 19813461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of renal impairment on the disposition of orally administered enalapril, benazepril, and their active metabolites.
    Lefebvre HP; Laroute V; Concordet D; Toutain PL
    J Vet Intern Med; 1999; 13(1):21-7. PubMed ID: 10052059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of experimental renal impairment on disposition of marbofloxacin and its metabolites in the dog.
    Lefebvre HP; Schneider M; Dupouy V; Laroute V; Costes G; Delesalle L; Toutain PL
    J Vet Pharmacol Ther; 1998 Dec; 21(6):453-61. PubMed ID: 9885968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of kinin and prostaglandin inhibitors on the renal response to angiotensin-converting enzyme inhibition: a micropuncture study in the dog.
    Heller J; Kramer HJ; Horácek V
    Pflugers Arch; 1994 Jun; 427(3-4):219-24. PubMed ID: 8072839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid chromatography-mass spectrometry method for determination of ramipril and its active metabolite ramiprilat in human plasma.
    Zhu Z; Vachareau A; Neirinck L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 779(2):297-306. PubMed ID: 12361743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tight binding of ramiprilat to ACE: consequences for pharmacokinetic and pharmacodynamic measurements.
    Brockmeier D
    Int J Clin Pharmacol Ther; 1995 Dec; 33(12):631-8. PubMed ID: 8963479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.